Ligand validation:2Z64

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 2Z64 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2Z64_NAG_C_1501	35%	47%	0.161	0.847	0.74	1.3	1	1	1	0	100%	0.9333
2Z64_NAG_A_1471	22%	56%	0.231	0.846	0.52	1.15	-	1	0	1	100%	0.9333
2Z64_NAG_C_1511	17%	62%	0.325	0.908	0.5	0.94	-	1	0	1	100%	0.9333
2Z64_NAG_C_1521	15%	50%	0.269	0.834	0.75	1.17	-	1	0	1	100%	0.9333
2Z64_NAG_A_1431	9%	58%	0.223	0.711	0.59	0.99	-	1	0	0	100%	0.9333
2Z64_NAG_A_1481	7%	58%	0.308	0.758	0.68	0.92	-	-	0	1	100%	0.9333
2Z64_NAG_A_1441	4%	51%	0.37	0.758	0.52	1.35	-	3	0	1	100%	0.9333
2Z64_NAG_A_1451	3%	51%	0.354	0.684	0.49	1.37	-	2	0	1	100%	0.9333
2Z64_NAG_A_1491	1%	54%	0.441	0.551	0.62	1.13	-	2	0	0	100%	0.9333
3VQ2_NAG_A_800	48%	10%	0.168	0.911	1.87	2.43	1	4	0	0	100%	0.9333
5IJB_NAG_C_201	45%	42%	0.129	0.859	0.54	1.69	-	2	0	0	100%	0.9333
3VQ1_NAG_B_802	30%	61%	0.27	0.934	0.5	0.98	-	1	1	0	100%	0.9333
5IJD_NAG_D_803	25%	13%	0.207	0.843	0.96	2.96	-	8	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
5O59_NAG_A_601	100%	70%	0.024	0.993	0.3	0.85	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.